DOCSLIB.ORG

2019 Annual Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2019 Annual Report Annual Report 2019 Garvan Institute of Medical Research Annual Report 2019 2019 Strength through collaboration Our vision Our values We see a future where everyone lives a longer, healthier life. Excellence Our mission Innovation We will harness all the information encoded in the genome Collaboration to better diagnose, predict, treat and prevent diseases that have the deepest impact on society. Community Integrity Respect Who we are, what we do The Garvan Institute of Medical Research brings together world-leading clinicians and basic and translational researchers. We are patient focused. Our researchers break down barriers between traditional scientific disciplines to find solutions to disease. Founded in 1963, Garvan’s researchers have made significant advances in genome, epigenome, protein and cell analysis technology. We have revealed causes and developed treatments for diseases including diabetes, osteoporosis, cancer, immune deficiency and autoimmunity. Today, Garvan’s mission builds on those advances, harnessing all the information encoded in our genome, from DNA to complex organ systems, to better diagnose, treat, predict and prevent disease. Garvan’s research has global impact. World-leading people pioneer discoveries across four intersecting research themes. We lead the field in medical genomics, epigenetics, and cellular genomics; cancer; diseases of immunity and inflammation; and diseases of ageing affecting bone, brain and metabolism. Our goal is to translate discovery into meaningful health benefits for those living with disease and their family. Patients, clinical trial cohorts and population cohorts are at the centre of Garvan’s research. We are focused on addressing the unmet needs of those living with disease – where better understanding, new treatments and more effective diagnosis can have the biggest impact. Through cutting-edge technology, facilities, local and international collaborations, Garvan researchers strive, every day, to create a future where everyone lives longer, healthier lives. Garvan’s research is funded through a crucial combination of peer-reviewed government grants and generous philanthropic investment from the community. Garvan is affiliated with St Vincent’s Hospital Sydney and UNSW Sydney. garvan.org.au 1 The organisation As at 31 December 2019 Garvan Institute of Medical Research Board of Directors Executive Leadership Team Chair: Dr John Schubert ao Executive Director: Prof Christopher Goodnow faa frs Deputy Director: Prof Peter Croucher Chief Scientifi c Offi cer: Prof Marie Dziadek Theme Leaders: Prof Susan Clark faa, Prof Peter Croucher, Prof Stuart Tangye, Prof David Thomas Chief Operating Offi cer: Ms Kate Gunn (until December) Acting Chief Operating Offi cer: Ms Samantha Malone and Ms Amanda Brindley (from December) Director of People Culture: Cleo Rowley Director of Garvan Research Foundation: Mara-Jean Tilley Healthy Ageing Cancer Genomics & Epigenetics Immunity & Infl ammation Theme Leader: Theme Leader: Theme Leader: Theme Leader: Prof Peter Croucher Prof David Thomas Prof Susan Clark faa Prof Stuart Tangye Faculty: Faculty: Faculty: Faculty: A/Prof Paul Baldock Dr Christine Chaffer Dr Ozren Bogdanovic Prof Robert Brink Prof Jacqueline Center Dr David Croucher Prof Vanessa Hayes Prof Daniel Christ Prof Tuan Nguyen A/Prof Elgene Lim Dr Timothy Mercer Dr Tatyana Chtanova Prof Mike Rogers Prof Chris Ormandy Prof Seán O’Donoghue A/Prof Elissa Deenick A/Prof Antony Cooper Dr Marina Pajic Dr Robert Weatheritt Prof Christopher Goodnow Prof Trevor Biden A/Prof Joseph Powell Emeritus Fellow: faa frs Prof Jerry Greenfi eld A/Prof Alex Swarbrick Prof John Shine ac faa A/Prof Shane Grey A/Prof Ross Laybutt A/Prof Paul Timpson A/Prof Cecile King Prof Katherine Samaras A/Prof Cindy Ma A/Prof Carsten Schmitz-Peiffer The Kinghorn Cancer A/Prof Tri Phan Prof Herbert Herzog Centre Director: Prof Jonathan Sprent faa frs Prof David Ryugo Prof David Thomas Emeritus Fellow: Emeritus Fellow: Prof Antony Basten ao faa Prof Lesley Campbell am Emeritus Fellow: Prof Don Chisholm ao Emeritus Fellow: Prof John Eisman ao Emeritus Fellow: Prof Ted Kraegen ao Kinghorn Centre for Clinical Genomics Garvan-Weizmann Centre for Cellular Genomics Clinical Head: Mary-Anne Young Head: A/Prof Joseph Powell Scientifi c Head: A/Prof Sarah Kummerfeld Garvan Research Foundation Board of Directors Executive Chair: Mr Russell Scrimshaw Director: Ms Mara-Jean Tilley Deputy Director: Mr Brad Timms The Services Team Chief Operating Offi cer: Ms Kate Gunn (until December) Chief Scientifi c Offi cer: Prof Marie Dziadek Acting Chief Operating Offi cer: Ms Samantha Malone and Grants Administration: Ms Sonja Bates, Ms Grainne Mullen Ms Amanda Brindley (from December) (until May) and Ms Mariette Le Roux (from May) Australian BioResources: Dr Jenny Kingham Human Research Governance: Ms Therese Yim Business Development & Innovation: David Barda Research Ethics and Compliance: Dr Rayson Tan Facilities Business: Amanda Brindley Animal Welfare: Dr Sarah Leonhard Finance & Accounting: Ms Samantha Malone Student Programs: Dr Tracy Anderson Internal Audit & Business Improvement: Ms Carolyn Loughnan Technology Services: Mr Esteve Mayolas Legal Offi ce: Ms Nancy Campisi Building Services: Ms Lynn Croft Building Operations: Mr Ryan Kolster People & Culture Director: Ms Cleo Rowley WHS and Compliance: Ms Abril Rojas-Crisostomo 2 garvan.org.au The organisation As at 31 December 2019 Contents Garvan Institute of Medical Research Board of Directors Executive Leadership Team 4 Garvan Institute Chairman and Executive Chair: Dr John Schubert ao Executive Director: Prof Christopher Goodnow faa frs Director’s Report Deputy Director: Prof Peter Croucher Chief Scientifi c Offi cer: Prof Marie Dziadek 5 Garvan Research Foundation Chairman Theme Leaders: Prof Susan Clark faa, Prof Peter Croucher, Prof Stuart Tangye, and Director’s Report Prof David Thomas Chief Operating Offi cer: Ms Kate Gunn (until December) 6 The year at a glance Acting Chief Operating Offi cer: Ms Samantha Malone and Ms Amanda Brindley (from December) Garvan at a glance Director of People Culture: Cleo Rowley 7 Director of Garvan Research Foundation: Mara-Jean Tilley 8 Collaborations Healthy Ageing Cancer Genomics & Epigenetics Immunity & Infl ammation Publications Theme Leader: Theme Leader: Theme Leader: Theme Leader: 9 Prof Peter Croucher Prof David Thomas Prof Susan Clark faa Prof Stuart Tangye Faculty: Faculty: Faculty: Faculty: 11 Theme Report: Healthy Ageing A/Prof Paul Baldock Dr Christine Chaffer Dr Ozren Bogdanovic Prof Robert Brink Prof Jacqueline Center Dr David Croucher Prof Vanessa Hayes Prof Daniel Christ 15 New hope for Parkinson’s Prof Tuan Nguyen A/Prof Elgene Lim Dr Timothy Mercer Dr Tatyana Chtanova Prof Mike Rogers Prof Chris Ormandy Prof Seán O’Donoghue A/Prof Elissa Deenick 16 Theme Report: Immunity and Inflammation A/Prof Antony Cooper Dr Marina Pajic Dr Robert Weatheritt Prof Christopher Goodnow How medical research changed a young Prof Trevor Biden A/Prof Joseph Powell Emeritus Fellow: faa frs 19 girl’s life Prof Jerry Greenfi eld A/Prof Alex Swarbrick Prof John Shine ac faa A/Prof Shane Grey A/Prof Ross Laybutt A/Prof Paul Timpson A/Prof Cecile King 21 Theme Report: Genomics and Epigenetics 38 Garvan Institute of Medical Research Board Prof Katherine Samaras A/Prof Cindy Ma of Directors A/Prof Carsten Schmitz-Peiffer The Kinghorn Cancer A/Prof Tri Phan 25 White Butterfly spreads its wings Prof Herbert Herzog Centre Director: Prof Jonathan Sprent faa frs 41 Garvan Research Foundation Board of Directors Prof David Ryugo Prof David Thomas Emeritus Fellow: 27 Theme Report: Cancer Emeritus Fellow: Prof Antony Basten ao faa PhD Completions Prof Lesley Campbell am 44 Research Services at Garvan Emeritus Fellow: 30 Prof Don Chisholm ao 45 Post-Doctoral Development Committee Emeritus Fellow: 32 Centre Report: Kinghorn Centre for Prof John Eisman ao Clinical Genomics 46 Leaders in Science and Society seminars Emeritus Fellow: Prof Ted Kraegen ao 34 Centre Report: Garvan-Weizmann Centre for 48 In Memoriam Cellular Genomics Kinghorn Centre for Clinical Genomics Garvan-Weizmann Centre for Cellular Genomics 49 Mr Rick Stevens: Clinical Head: Mary-Anne Young Head: A/Prof Joseph Powell 36 Awards and accolades The future of medical research is in good hands Scientifi c Head: A/Prof Sarah Kummerfeld 50 Partners for the Future Garvan Research Foundation Board of Directors Executive 54 Garvan community Chair: Mr Russell Scrimshaw Director: Ms Mara-Jean Tilley 60 Celebrating pioneering partnerships Deputy Director: Mr Brad Timms The Services Team 63 Scientific publications Chief Operating Offi cer: Ms Kate Gunn (until December) Chief Scientifi c Offi cer: Prof Marie Dziadek 81 Peer-reviewed funding Acting Chief Operating Offi cer: Ms Samantha Malone and Grants Administration: Ms Sonja Bates, Ms Grainne Mullen Ms Amanda Brindley (from December) (until May) and Ms Mariette Le Roux (from May) 87 Join the Garvan family Australian BioResources: Dr Jenny Kingham Human Research Governance: Ms Therese Yim Business Development & Innovation: David Barda Research Ethics and Compliance: Dr Rayson Tan 88 Financial highlights Facilities Business: Amanda Brindley Animal Welfare: Dr Sarah Leonhard Finance & Accounting: Ms Samantha Malone Student Programs: Dr Tracy Anderson We acknowledge the Gadigal and Gundangara peoples, Internal Audit & Business Improvement: Ms Carolyn Loughnan the traditional owners and custodians of the lands on Technology Services: Mr Esteve Mayolas which the Garvan Institute and the ABR are
Load more

Recommended publications
  • The John Curtin School of Medical Research Annual Review 2012
    THE JOHN CURTIN SCHOOL OF MEDICAL RESEARCH ANNUAL REVIEW 2012 ANU College of Medicine, Biology & Environment CONTENTS Annual Review 2012 From the Director 3 The John Curtin School of Medical Organisation Chart 4 Research Committees 5 COMMUNITY 7 Official Opening of Stage 3 8 Launch of The John Curtin Medical Research Foundation 9 Professor Gordon Ada 10 Open Day 11 Community Activities 12 RESEARCH IN REVIEW 2012 15 Eccles Institute of Neuroscience 16 Department of Genome Biology 29 Department of Immunology 36 Department of Pathogens and Immunity 45 Department of Molecular Bioscience 47 Department of Translational Medicine 56 Australian Phenomics Facility 60 Biomolecular Resource Facility/Genome Discovery Unit 61 STAFF AND STUDENT ACHIEVEMENTS 63 VISITORS AND COLLABORATIONS 69 STAFF AND STUDENTS 85 Department of Genome Biology 86 Department of Immunology 87 Eccles Institute of Neuroscience 88 Department of Pathogens and Immunity 90 Department of Molecular Bioscience 90 Department of Translational Medicine 92 APF and Animal Services 92 School Services 94 School Administration 95 Students 96 PUBLICATIONS, PRESENTATIONS AND COMMUNITY OUTREACH 99 SUPPORT 129 Grants 130 Financial Overview 134 Donors 135 Sponsors 136 Annual Review 2012 1 2 The John Curtin School of Medical Research FROM THE DIRECTOR Zinkernagel. He will be sadly missed by his many friends and colleagues at the School, who have established the annual Gordon Ada New Investigator Award in his memory. In 2012, we finally completed the long and very necessary redevelopment project that resulted in the new John Curtin School of Medical Research building on the ANU campus. All our staff and students are once again under one roof, carrying out their research in state of the art laboratories and facilities.
    [Show full text]
  • Understanding Genomics
    Predict Diagnose Treat Understanding genomics A comprehensive guide brought to you by Garvan. Contents What is genomics? 4 A short history of DNA 5 Genomics information for a lifetime 7 Conversations about genomics 11 How does genome sequencing work? 12 Can I have my genome sequenced? 13 Genomics research at Garvan 14 Garvan’s genomics research programs 18 Genomics research centres 20 Useful terms 22 Predict Diagnose Treat 2 3 Professor Chris Goodnow FAA FRS Executive Director, Garvan Institute of Medical Research The Bill and Patricia Ritchie Foundation Chair Dear Friend, I’m Professor Chris Goodnow, Executive Director of the Garvan Institute of Medical Research in Sydney. I wanted to introduce myself and thank you for your interest in understanding genomics. Genomics is the study of genes and other information encoded in an individual’s genome—the complete set of instructions in their DNA. Each person has different DNA, unique just to you. Every disease has a genetic component. Through genomics research, we can further understand what our genetic information – and our gene or genetic variations – mean for our health. Garvan scientists use genomics research to understand more about disease and determine how to best diagnose, treat and prevent it. I hope you find this brochure informative and useful and consider joining our family, pioneering the future of medical research. Yours sincerely, Chris We see a future where an individual’s DNA is used to better predict, diagnose and treat disease. It’s within reach. 2 3 What is genomics? Genomics is the study of your genome – all the information encoded in your DNA.
    [Show full text]
  • Annual Report (March 2010-February 2011)
    EMBL Australia Annual Report [March 2010 – February 2011] 2 EMBL AUSTRALIA ANNUAL REPORT 2009–10 Contents Chairman’s report 2 Scientific Head’s report 3 About EMBL Australia 4 The European Molecular Biology Laboratory 4 2010 Highlights 5 2011 Outlook 6 Key activities 7 Launch by Minister Carr 7 Appointment of Scientific Head 8 EBI Mirror Facility and the National Bioinformatics Network 8 EBI Mirror at The University of Queensland 8 EMBL Australia Bioinformatics Network 9 International PhD Program 9 Partner Laboratory Network 9 Appointment of Edwina McGlinn 10 Appointment of Nicolas Platcha 11 Faculty Development Program 11 Sponsorship of BioInfoSummer 11 Governance 12 EMBL Australia participant expansion 12 Council 12 Appointment of new members 12 Council Members 12 Meetings 12 Planning and Finance Committee 13 Members 13 Meetings 13 Bioinformatics Committee 13 Members 13 Meetings 13 Staff 14 Australian visitors to EMBL 2010 15 Visitors to EMBL Australia 15 Financial report 16 Documents and Media releases 18 Funding & Stakeholders 20 Participants 20 Funding and in-kind support 20 Contact details inside back cover 1 Chairman’s report 2010 was a seminal year in the EMBL Australia initiative. Our official launch by Minister Carr in March coincided with the announcement of several key developments. These developments included the appointments of our Scientific Head and first Partner Laboratory Group Leaders, along with the announcement of a second node and associated national network for bioinformaticians. EMBL Australia’s participation is set to expand, with invitations accepted by the remaining Go8 universities to join EMBL Australia. This will extend direct involvement to a wider group of research institutions and expand the potential reach of EMBL Australia programs.
    [Show full text]
  • June 06.Indd
    NEWSLETTER Australasian Society for Immunology Incorporated PP 341403100035 ISSN 1442-8725 June 2006 Overview of the JCSMR Immunogenomics Laboratory 2006 Gerard Hoyne Overview they were able to reveal that the autoimmune but Dr Horikawa, a postodoctoral fellow in The Immunogenomics Laboratory at the regulator gene AIRE, which is expressed by the lab, has made the remarkable fi nding that John Curtin School of Medical Research in a subset of thymic epithelial cells, plays a the exact opposite is the case. The memory Canberra comprises four research groups critical role in establishing T cell tolerance B cell receptor is less active at inducing a working in concert to develop an integrated to self antigens in the thymus. In addition, subset of genes, and in this case less signal understanding of how our immune system is Adrian also identifi ed that defective signals means more antibody formation. controlled at the cellular and molecular level to cell death genes account for the inherited by circuits that are specifi ed in our genome resistance of T lymphocytes to clonal deletion Carola Vinuesa heads the Humoral sequence. Each of the groups focuses on in the thymus of NOD mice. Upon infection memory and Autoimmunity Group. a different element of a fundamental set with a virus or bacteria, B lymphocytes with Her group is investigating the cellular and of immune system decisions made at the the right antigen receptors to neutralize molecular events that regulate production level of individual immune system cells: infection are stimulated to switch the isotype and selection versus elimination of memory either to fi ght or to disarm.
    [Show full text]
  • THE JOHN CURTIN SCHOOL of MEDICAL RESEARCH Annual Review 2013
    THE JOHN CURTIN SCHOOL OF MEDICAL RESEARCH Annual Review 2013 ANU College of Medicine, Biology & Environment CONTENTS Annual Review 2013 The John Curtin School of Medical Research From the Director 3 Staff and student lists 87 Department of Genome Biology 88 Organisation Chart 4 Department of Immunology 90 Committees 5 Eccles Institute of Neuroscience 92 Department of Molecular Bioscience 94 Community 7 Department of Translational Medicine 96 Department of Pathogens and Immunity 96 Centenary of Canberra 2013 Australian Phenomics Facility 97 14th Frank and Bobbie Fenner Conference 8 School Administration 98 The John Curtin Medical Research Foundation Dinner 9 School Services 98 David Curtis Reading Room 10 The ACRF Biomolecular Resource Facility Open Day 2013 11 and Genome Discovery Unit 99 Community Activities 12 Students 100 Research in Review 2013 15 Publications, presentations and Eccles Institute of Neuroscience 16 community outreach 103 Department of Genome Biology 30 Publications 104 Department of Immunology 38 Staff Presentations 110 Department of Pathogens and Immunity 48 Student Presentations 117 Department of Molecular Bioscience 52 Community Outreach 121 Department of Translational Medicine 58 Australian Phenomics Facility 60 Support to JCSMR 131 The Imaging and Cytometry Facility 62 Grants 132 The ACRF Biomolecular Resource Facility Financial Overview 136 and Genome Discovery Unit 63 Donors 137 Staff and student achievements 65 Sponsors 138 Graduates 66 Prizes and Awards 67 Visitors and collaborations 71 Visitors 72 Collaborations 74 Annual Review 2013 1 2 The John Curtin School of Medical Research FROM THE DIRECTOR Following the opening of Stage 3 of our new building in 2012, JCSMR staff and students have enjoyed the opportunities provided by the new spaces, including the laboratories, and meeting rooms such as the Science Forum.
    [Show full text]
  • 2018 Annual Report 2018 Our Year of Big Thinking, Collaboration and Discovery
    2018 Annual Report 2018 Our year of big thinking, collaboration and discovery. Our vision Our values We see a future where everyone lives a longer, Excellence healthier life. Innovation Our mission Collaboration We will harness all the information encoded in Community the genome to make pioneering discoveries that Integrity predict, treat and prevent diseases that have the deepest impact on society. Respect 2018 Garvan Annual Report Our values Who we are, what we do Aspirations Excellence Garvan is leading the nation in using genomic analysis • To become the most advanced institute in the to accelerate discovery and enable personalised, region in the adoption, application and integration Innovation precision medicine. of next-generation genomic and computational approaches and technologies in investigative and Collaboration Our researchers pioneer studies into some of the most translational research. difficult to solve and widespread diseases affecting the Community community today. Garvan is focused on understanding • To advance knowledge in our key areas of critical the molecular and cellular processes in health and mass that will lead to better understanding, reduced Integrity disease, putting people and patients at the centre of incidence and improved treatments for cancer, leading-edge local and global research expertise and immune deficiency, inflammatory and autoimmune Respect networks as the basis for developing future preventions diseases including diabetes, osteoporosis, and and treatments. diseases of ageing affecting the brain and other organs. For 56 years, Garvan scientists have been achieving significant breakthroughs in the understanding and • To attract, develop and support exceptionally talented treatment of diseases. researchers with leading-edge programs addressing key conceptual and practical questions in human biology, and the translation of new knowledge and technologies into clinical applications.
    [Show full text]
  • 2017 Annual Report GARVAN INSTITUTE of MEDICAL RESEARCH MISSION and VISION
    BREAKTHROUGH MEDICAL RESEARCH 2017 Annual Report GARVAN INSTITUTE OF MEDICAL RESEARCH MISSION AND VISION To make significant contributions to medical research that will change the directions of science and medicine and have major impacts on human Respect Passion health. Garvan’s ultimate goal is prevention and treatment of major diseases. Collaboration Values Excellence Innovation Integrity Who we are, Aspirations • To attract, develop and support exceptionally talented what we do • To become the most researchers with leading‑edge advanced institute in the programs addressing key Garvan is leading the nation region in the adoption, conceptual and practical in using genomic analysis to application and integration of questions in human biology, accelerate discovery and enable next‑generation genomic and and the translation of new personalised, precision medicine. computational approaches and knowledge and technologies technologies in investigative into clinical applications. Our researchers pioneer and translational research. studies into some of the most • To embrace and uphold a culture widespread diseases affecting • To advance knowledge in our of collegiality, collaboration, the community today. Garvan is key areas of focus that will inclusivity, consideration, focused on understanding the lead to better understanding, safety, transparency, and role of molecular and cellular reduced incidence and high ethical standards. processes in health and disease improved treatments for cancer, as the basis for developing future osteoporosis, diabetes, obesity, • To engage stakeholders preventions and treatments. and immunological, skeletal and and the community with our neurological diseases, and achievements and research For 55 years, Garvan to influence health policy. vision so that we attract the scientists have been achieving significant government and significant breakthroughs donor support needed in the understanding and to empower our treatment of diseases.
    [Show full text]
  • Breakthrough Magazine June E Corkery Angele Labossiere Eric Swarbrick Please Visit Garvan.Org.Au/Previous-Seminars
    August 2018 | Issue 39 breakthrough Trust your gut How your bacteria could save you from type 2 diabetes Meet Professor Chris Goodnow, Garvan’s new Executive Director Living an extraordinary life with rare cancer Welcome NEW RESEARCH from our It’s DNA, but not as we know it Executive In a world first, our researchers Associate Professor Daniel Christ, Associate Professor Marcel Dinger and Director Dr Mahdi Zeraati found a new DNA structure – a twisted ‘knot’ they call the i-motif – inside cells. The iconic ‘double helix’ shape of DNA has captured the public imagination since 1953; however, it’s now known that DNA can exist Dear Garvan family, in a few other shapes – in a test tube, at least. Until now, the i-motif had never before been directly seen inside I’m so pleased to be able to introduce your August issue of living cells. In fact, scientists had debated whether i-motif Breakthrough and to have this opportunity to thank you for ‘knots’ would exist at all inside living things – a mystery your support. Many of you know me from my three years as that is now solved. Garvan researchers suspect i-motif Deputy Director here at Garvan. I’m honoured to have been DNA plays an important role in switching genes on or off. appointed as the Institute’s fourth Executive Director and build on the legacy of the Institute’s pre-eminent leaders. See the i-motif DNA at garvan.org.au/new-dna. I’d like to briefly share with you my vision for the future of Garvan, in which we continue our progress towards precision medicine based on each person’s DNA.
    [Show full text]
  • BAR Winter Text 03 #6
    CONTENTS Editor’s note 2 Letters to the editor 2 A message from the President 3 Opinion Protecting our interests: The proper role of the Bar Council 5 The Lucky Boat and the future of the Australian Bar Association 7 Addresses Negligence and insurance premiums: Recent changes in Australian law 10 Features Professional liability of barristers 21 Fixing the Crimes Act 27 Bar News A new approach to sentencing 31 The JOURNAL of the NSW BAR ASSOCIATION Settlement being the value of the lost cause of action 32 Winter 2003 Bench and Bar Dinner 2003 36 Mediation Editorial Board Court ordered mediation: Is it undesirable? 39 Justin Gleeson S C (Editor) Mediation in the Family Court of Australia: A legal framework 42 Andrew Bell Rodney Brender Bar Association initiatives Rena Sofroniou Childcare for barristers 44 Ingmar Taylor Chris O’Donnell History Chris Winslow Owen Dixon 45 (Bar Association) High Court appointments up to its jubilee year 47 Editorial Print/Production Interview Rodenprint Interview with Phillipa Gormly 48 Personalia Layout ‘The dancing man’: Frank McAlary QC 52 Hartrick’s Design Office Pty Ltd Book reviews 54 Advertising Vale Bar News now accepts advertisements. Robyn Ashes 58 For more information, contact Chris Winslow at the George Hillary Smith QC 59 NSW Bar Association on The Hon Robert St John QC 60 (02) 9229 1732 or e-mail cwinslow@nswbar.asn.au Readers 01/03 – Photo 62 Appointments Cover The Hon Justice J D Heydon 63 Frank McAlary, ‘The Dancing Man’, in Elizabeth Street, Sydney, during victory The Hon Justice A C Bennett 64 celebrations on VJ Day, The Hon Justice J W Shaw 65 15 August 1945.
    [Show full text]
  • Garvan Institute's Guide to Positive Ageing
    Positive ageing A comprehensive guide brought to you by Garvan. PB 1 Contents Introduction 1 What is healthy ageing? 2 What happens to your body as it ages 4 Diseases of ageing 12 Healthy ageing – what you can do 14 Garvan & diseases of ageing 16 Medical Genome Reference Bank 24 We see a future where everyone lives longer, healthier lives. 1 Professor Chris Goodnow FAA FRS Executive Director, Garvan Institute of Medical Research The Bill and Patricia Ritchie Foundation Chair Dear Friend, I’m Professor Chris Goodnow, Executive Director of the Garvan Institute of Medical Research, one of Australia’s premier research facilities. I wanted to introduce myself and thank you for requesting our brochure on positive ageing. As precision medicine and advances in healthcare enable people to live longer than ever before, the ability to live not only long, but healthy lives is becoming increasingly critical. We know that ageing healthily relies on a complex mix of genetic, environmental and social factors. However, there are actions that can be taken now to help ensure that older adults maintain their physical and emotional health, whatever their age or circumstances. We are focused on addressing the unmet needs of those living with disease – where better understanding, new treatments and more effective diagnosis can have the biggest impact in order to create a future where people can live longer, healthier lives. Yours sincerely, Chris We see a future where an individual’s DNA is used to better predict, diagnose and treat disease. It’s within reach. 1 What is healthy ageing? With age comes the increased risk of disease or infirmity.
    [Show full text]
  • Mutations, Tolerance Checkpoints, Autoimmunity and Lymphoid Cancer
    Mutations, tolerance checkpoints, autoimmunity and lymphoid cancer PROFESSOR CHRISTOPHER C GOODNOW FAA FRS Executive Director, Garvan Institute of Medical Research ABSTRACT Distinguishing self from microbe is a fundamental problem for adaptive and innate immune receptors, balancing between the need for specificity and polyreactivity. Self-reactive antibodies are displayed as surface receptors on many B lymphocytes, and continuously signal responses within the B cell upon binding self antigens. A series of checkpoints and feedback mechanisms normally prevent these signals from activating relentless B cell proliferation and the potential for autoimmunity or lymphoma/leukemia. Here I will describe recent experiments analysinghow cells bypass these checkpoints by acquiring somatic mutations in the immunoglobulin V-regions and in lymphoma driver genes. 31 Thursday 1 August, 2019 ABOUT THE PRESENTER 1:00 - 2:00pm Professor Chris Goodnow FAA FRS is Executive Director of the Garvan Institute of Medical Research, holds The Bill and Patricia Ritchie Foundation H1 Lecture Theatre, Chair as Head of the Immunogenomics Laboratory at Garvan, and is Professor and Director of the Cellular Genomics Futures Institute at UNSW 20 Chancellors Walk Sydney. Chris trained in veterinary medicine and surgery, immunochemistry, Clayton campus and immunology at the University of Sydney and in DNA technology at Stanford University. Chris is internationally recognised for discovering and establishing the concept of sequential checkpoints for the immune system to tolerate “self” while fighting off “foreign” infections, laying the scientific foundation for the recent success of checkpoint inhibitor drugs to activate immune destruction of “self” cancer cells. He pioneered the use of genome sequencing to reveal how the body’s phenotype results from its’ genotype – “phenomics”.
    [Show full text]
  • BAR Winter Text 03 #6
    SWEARINGS-IN attend your Honour's equity lectures; not The Hon Justice because it was compulsory and not because they were the only lectures, but John Dyson Heydon because of your Honour's strong expository style was of a kind which even On 11 February 2003 the Hon Justice we…understood was not likely to be Dyson Heydon was sworn in as a judge of replicated to the same quality anywhere else. the High Court of Australia, the 44th such appointment since the court’s Your Honour's teaching style could not be establishment in 1903. described as having succumbed to any new-fangled techniques of pedagogy. His Honour was welcomed to the Conversation was not encouraged, of any Bench by the Commonwealth Attorney- kind, and there was no pretence on your General, the Hon Daryl Williams AM QC Honour's part that there was any MP, the President of the Law Council of intellectual, cognitive, academic, scholarly Australia, Ron Heinrich, the President of or legal equality of interchange between the Australian Bar Association, A J Glynn lecturer and lectured. That approach had SC and the President of the New South two great advantages: first, it was entirely Justice Dyson Heydon after his High Court Wales Bar Association, Bret Walker SC. accurate; and, second, it permitted those swearing-in ceremony. Photo: News Archive The Attorney recounted for the of us on the unfavourable side of the assembled guests Justice Heydon’s comparison to try and do something about commented that during his three years on considerable scholastic achievements. bridging the unbridgeable gap.
    [Show full text]